NO174962C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater

Info

Publication number
NO174962C
NO174962C NO901176A NO901176A NO174962C NO 174962 C NO174962 C NO 174962C NO 901176 A NO901176 A NO 901176A NO 901176 A NO901176 A NO 901176A NO 174962 C NO174962 C NO 174962C
Authority
NO
Norway
Prior art keywords
tetranor
inter
preparation
therapeutically active
analogous process
Prior art date
Application number
NO901176A
Other languages
English (en)
Norwegian (no)
Other versions
NO901176L (no
NO901176D0 (no
NO174962B (no
Inventor
Kiyotaka Ohno
Atsushi Ohtake
Takashi Endoh
Shigeki Itou
Kazuhiro Hoshi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO901176D0 publication Critical patent/NO901176D0/no
Publication of NO901176L publication Critical patent/NO901176L/no
Publication of NO174962B publication Critical patent/NO174962B/no
Publication of NO174962C publication Critical patent/NO174962C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Furan Compounds (AREA)
  • Liquid Crystal Substances (AREA)
NO901176A 1989-03-14 1990-03-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater NO174962C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6324189 1989-03-14

Publications (4)

Publication Number Publication Date
NO901176D0 NO901176D0 (no) 1990-03-13
NO901176L NO901176L (no) 1990-09-17
NO174962B NO174962B (no) 1994-05-02
NO174962C true NO174962C (no) 1994-08-10

Family

ID=13223534

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901176A NO174962C (no) 1989-03-14 1990-03-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater

Country Status (12)

Country Link
US (1) US5086071A (ko)
EP (1) EP0389162B1 (ko)
JP (1) JP2893812B2 (ko)
KR (1) KR960016542B1 (ko)
AT (1) ATE98239T1 (ko)
AU (1) AU621996B2 (ko)
CA (1) CA2012081C (ko)
DE (1) DE69005006T2 (ko)
DK (1) DK0389162T3 (ko)
ES (1) ES2060944T3 (ko)
FI (1) FI901277A0 (ko)
NO (1) NO174962C (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053180T3 (es) * 1989-02-27 1994-07-16 Toray Industries Preparacion de derivados pgi 2 de 5,6,7-trinor-4,8-inter-m-fenileno pgi 2.
CA2254925A1 (en) * 1997-03-13 1998-09-17 Shigeyasu Annoh Drugs for relieving diabetic vascular lesion
EP0947195A4 (en) * 1997-03-14 1999-12-01 Toray Industries NERVOUS CELL PROTECTIVE AGENTS
WO1999013881A1 (fr) * 1997-09-17 1999-03-25 Toray Industries, Inc. Agent de maturation cervical
CA2340375A1 (en) * 1999-06-14 2000-12-21 Hiroshi Maeda Agent for enhancing accumulation of drugs in tumor tissues
JP4503942B2 (ja) * 2003-06-11 2010-07-14 大正製薬株式会社 止痒剤
TW202317089A (zh) 2021-06-16 2023-05-01 日商東麗股份有限公司 罹患慢性腎臟病的貓的治療方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
ES2029799T3 (es) * 1986-01-24 1992-10-01 Toray Industries, Inc. Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
US4880939A (en) * 1986-12-11 1989-11-14 Toray Industries 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives
DE3886936T2 (de) * 1987-10-16 1994-04-28 Toray Industries 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
ES2053180T3 (es) * 1989-02-27 1994-07-16 Toray Industries Preparacion de derivados pgi 2 de 5,6,7-trinor-4,8-inter-m-fenileno pgi 2.

Also Published As

Publication number Publication date
KR960016542B1 (ko) 1996-12-14
NO901176L (no) 1990-09-17
AU621996B2 (en) 1992-03-26
ATE98239T1 (de) 1993-12-15
ES2060944T3 (es) 1994-12-01
CA2012081A1 (en) 1990-09-14
NO901176D0 (no) 1990-03-13
EP0389162A1 (en) 1990-09-26
DK0389162T3 (da) 1994-02-14
US5086071A (en) 1992-02-04
NO174962B (no) 1994-05-02
AU5131890A (en) 1990-09-20
EP0389162B1 (en) 1993-12-08
JPH037275A (ja) 1991-01-14
KR900014348A (ko) 1990-10-23
CA2012081C (en) 2000-08-29
DE69005006D1 (de) 1994-01-20
DE69005006T2 (de) 1994-05-11
FI901277A0 (fi) 1990-03-14
JP2893812B2 (ja) 1999-05-24

Similar Documents

Publication Publication Date Title
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
FI94340C (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI884660A (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
NO174962C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater
FI893426A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
PT89492A (pt) Processo de preparacao de novos derivados de tioformamida terapeuticamente activos
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI103885B (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
IE840151L (en) £(3, 4-methylenedioxy-ó-hydroxybenzyl| pyrrolidine¹antihypertensives
NO175099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater
NO179791C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser